Get Quick Answers From Turkish Manufacturers

     

SANDOZ ILAC SAN. VE TIC. A.S. Company Profile

Sandoz – A healthy decision in Generic Pharmaceuticals



Sandoz, a Novartis company, is a world leading generics pharmaceuticals company. The company develops, manufactures and markets off-patent medicines, as well as pharmaceutical and biotechnological active ingredients.

Sandoz, with its strong technology base, particularly in the application of “difficult-to-make” generic products (transdermal patches, inhalation products, sustained-release implants and multi-particulate drug-delivery dosage forms), is poised to be a leader in all aspects of generic pharmaceuticals, including biopharmaceuticals and anti-infectives. This reinforces the Sandoz Vision to go beyond traditional generic products and bring innovative technologies and delivery systems to market, making a world of difference in generics.



The company is competitive with its leading presence in key markets, including the US and Germany, and a comprehensive product portfolio of more than 840 compounds in more than 5,000 dosage forms. Its global network, registration and development strengths support the aim of Sandoz to achieve significant product approvals annually throughout the global organization. This is exhibited by a launch of more than 300 new products in 2006. It also supports the Sandoz Vision of being the main provider of high quality, affordable medicines helping secure long-term access to healthcare for people around the world.



Sandoz reported generic pharmaceutical sales in 2006 were USD 5.9 billion and employs more than 21,000 associates in 110 countries. Sandoz global headquarters are based in Holzkirchen, Germany, located just south of Munich.



Generic pharmaceuticals are the bioequivalent of an innovative, brand name product. This includes dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Generics are held to the same strict standards as the innovator product, dictated by the FDA and other regulatory agencies throughout the world. Although generic pharmaceuticals are chemically identical to their branded counterparts, they traditionally cost consumers less than the brand product.



The finished dosage forms are sold to wholesalers, pharmacies, hospitals and other healthcare outlets. Our Anti-Infectives unit manufactures active pharmaceutical ingredients and their intermediates for internal requirements and industrial partners.



Sandoz Image Brochure

Facts & Figures booklet

Novartis annual report







2007-06-22

Sandoz receives positive EU opinion for approval of epoetin alfa biosimilar



more



2007-04-24

Novartis with dynamic growth in the 2007 first quarter



more



2007-01-18

Novartis strategic healthcare portfolio drives sustained strong performance with record full-year results in 2006



more



2006-10-20

Novartis delivers dynamic sales and earnings growth in the first nine months of 2006, reaffirms outlook for record full-year results



more

patient governance, pharmacist governance, physician governance, pharmac, medicine manufacturer, medicine supplier, medicine exporter, medicines,

SANDOZ ILAC SAN. VE TIC. A.S. Products

Send Message to Company Detailed Form